// App-Quantinova.ai

POS0337 (2021) : SOUTHEND PRE-TEST PROBABILITY SCORE AND HALO SCORE AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: EARLY RESULTS FROM THE PROSPECTIVE HAS-GCA STUDY

Researchers

Presenter

  • A. Sebastian

Principal Investigators

  • A. Tomelleri

  • A. Kayani

  • D. Prieto-Pea

  • J. Jackson

  • K. Van der Geest

  • B. Dasgupta

Medical Centers

  • Mid and South Essex University Hospital Groups, Southend University Hospital, Rheumatology, Westcliff-on-sea, United Kingdom

  • University of Essex, School of Sport, Rehabilitation and Exercise science, Colchester, United Kingdom

  • IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR),, Milano, Italy

  • Marques de Valdecilla University Hospital, Santander, Spain

  • University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, Netherlands

Locations

  • United Kingdom

  • Italy

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche Holding AG

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved